Rapibloc 300 mg
Rapibloc 300 mg is a medicine authorised by Swissmedic under authorisation number 68611. The authorisation holder is OrPha Swiss GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 October 2022 and the authorisation is limited until 18 October 2027. ATC code C07AB14 places the medicine in the group Beta blocking agents.
| Authorisation number | 68611 |
|---|---|
| Name | Rapibloc 300 mg |
| Full name | Rapibloc 300 mg, Pulver zur Herstellung einer Infusionslösung |
| Authorisation holder | OrPha Swiss GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C07AB14 |
| First authorisation | 19 October 2022 |
| Authorisation validity | 18 October 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rapibloc 300 mg, Pulver zur Herstellung einer Infusionslösung | B | 19 October 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | C07AB14 | 02.03.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Rapibloc 300 mg authorised in Switzerland?
Yes. Rapibloc 300 mg is authorised by Swissmedic under authorisation number 68611, data as of 01 September 2026. The authorisation is limited until 18 October 2027.
Which dispensing category does Rapibloc 300 mg have?
Rapibloc 300 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rapibloc 300 mg?
The authorisation holder is OrPha Swiss GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.